The Eli Lilly story
What drives Eli Lilly, what its price assumes and what could change the story, written from its own filings.
- Volume outruns pricing. In the quarter to June 2026, revenue grew 48% to $23.0 billion as volume increased 60%, partly offset by a 13% decline in realized prices.
- Expansion absorbs cash. Lilly generated $10.7 billion of operating cash flow and spent $2.9 billion on plant and equipment in the quarter to June 2026 while also completing pipeline acquisitions.
- Cash expectations are demanding. At $1,157.08 per share, the reverse discounted cash flow calculation implies 23.5% annual growth in free cash flow after stock pay for ten years, versus 2.1% annually over the last 10 years.
